Intuitive Surgical, Inc. (ISRG)

Over the past six months, Intuitive Surgical's stock price has experienced various events and movements. Key events impacting the stock include the Q4 2024 and Q1 2025 earnings releases, the launch of da Vinci 5, an analyst downgrade by Deutsche Bank, FDA clearance for Vessel Sealer Curved, CE Mark for da Vinci 5 Surgical System, and a telesurgery demonstration. Over the past six months, Intuitive Surgical insiders have primarily sold shares, and members of Congress have also traded ISRG stock.

Intuitive Surgical experiences long and variable contracting cycles and seasonality in its business, which can lead to fluctuations in its financial results. The company's financial performance is driven by the sale of its surgical systems and recurring revenue from instruments, accessories, and services. The recurring nature of the Instruments & Accessories segment's revenue is tied to the continuous replenishment of single-use products for each robotic-assisted surgery. The company's stock seasonality profile indicates that July has historically been a "green month."

Intuitive Surgical, Inc. is an American biotechnology company specializing in robotic products for minimally invasive surgery, headquartered in Sunnyvale, California. The company's core business revolves around its robotic-assisted surgical systems, with its flagship product being the da Vinci Surgical System. The company's revenue model is significantly driven by recurring revenue from instruments, accessories, and services.

Intuitive Surgical has a significant global presence, with an installed base of systems exceeding 10,600 globally by the end of 2024. The company is actively expanding its global footprint, notably by establishing a direct presence in Italy, Spain, Portugal, Malta, and San Marino. Intuitive Surgical also owns properties in Mexicali, Mexico, primarily for manufacturing, and Aubonne, Switzerland, for its international headquarters.

Intuitive Surgical has built a strong brand reputation over the past year, recognized for its high-quality products and reliable performance. The company's reputation is bolstered by its extensive training programs for surgeons and the creation of a comprehensive ecosystem around its da Vinci system, fostering customer loyalty. The company acknowledges that significant negative publicity could damage its reputation, decrease product use, and lead to litigation and potential liability.

Intuitive Surgical is predominantly owned by institutional shareholders, who hold approximately 82.89% to 87% of the company. Individual investors hold about 16.30% to 48.02%, while Intuitive Surgical insiders own a smaller percentage, around 0.49% to 0.81%. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., and State Street Corp.